No Data
Novavax Put Volume Heavy and Directionally Bearish
FDA to Tighten Vaccine Approval Requirements: Reports
Trump Administration Said to Be Investing $500M on Developing Universal Vaccines
Novavax to Report First Quarter 2025 Financial Results on May 8, 2025
Press Release: Novavax Appoints Charles Newton to Board of Directors
Trump-Era FDA Appointees Request New Trials For Novavax COVID Vaccine, Reportedly Delaying Approval Timeline